ClinVar Miner

Submissions for variant NM_001159773.2(CANT1):c.1186G>C (p.Glu396Gln)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Lifecell International Pvt. Ltd RCV003991993 SCV004809183 uncertain significance Desbuquois dysplasia 1 criteria provided, single submitter clinical testing The missense variant NM_138793.4 (CANT1):c.1186G>C (p.Glu396Gln) has not been reported previously as a pathogenic variant nor as a benign variant, to our knowledge. The p.Glu396Gln variant is novel (not in any individuals) in gnomAD All. The p.Glu396Gln variant is novel (not in any individuals) in 1kG All. There is a small physicochemical difference between glutamic acid and glutamine. The p.Glu396Gln missense variant is predicted to be damaging by both SIFT and PolyPhen2. The glutamic acid residue at codon 396 of CANT1 is conserved in all mammalian species. The nucleotide c.1186 in CANT1 is predicted conserved by GERP++ and PhyloP across 100 vertebrates. Based on the above evidence this variant has been classified as Uncertain Significance according to the ACMG guidelines.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.